Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature

Case Reports in Oncological Medicine

Volumn 2015, Issue , 2015, Pages

  Khattab, Mohamed H ^a   Marciscano, Ariel E ^a   Lo, Simon S ^b   Lim, Michael ^a,c   Laterra, John J ^c   Kleinberg, Lawrence R ^a   Redmond, Kristin J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CD34 ANTIGEN; CHROMOGRANIN; CYCLOPHOSPHAMIDE; DESMIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUDARABINE; INTERLEUKIN 2; KERATIN; KI 67 ANTIGEN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; SYNAPTOPHYSIN; TEMOZOLOMIDE;

ABDOMINAL DISCOMFORT; ADULT; AFRICAN AMERICAN; ANTIANGIOGENIC THERAPY; APHERESIS; BACKACHE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; EXTRACRANIAL METASTASIS; FOLLOW UP; GLIOBLASTOMA; HERPES SIMPLEX ENCEPHALITIS; HOMONYMOUS HEMIANOPIA; HUMAN; LIFE EXPECTANCY; LUNG NODULE; MALE; MENTAL HEALTH; METASTASIS; METRONOMIC DRUG ADMINISTRATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MULTIPLE PULMONARY NODULES; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SPINDLE CELL CARCINOMA; TUMOR RECURRENCE;

EID: 84983519238     PISSN: 20906706     EISSN: 20906714     Source Type: Journal    
DOI: 10.1155/2015/431819     Document Type: Review

References (22)

1. R. Stupp, W. P. Mason, M. J. van den Bent et al. , "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, " The New England Journal of Medicine, vol. 352, no. 10, pp. 987-996, 2005.
2. M. Lun, E. Lok, S. Gautam, E. Wu, and E. T. Wong, "The natural history of extracranial metastasis from glioblastoma multiforme, " Journal of Neuro-Oncology, vol. 105, no. 2, pp. 261-273, 2011.
3. G. Kalokhe, S. A. Grimm, J. P. Chandler, I. Helenowski, A. Rademaker, and J. J. Raizer, "Metastatic glioblastoma: case presentations and a review of the literature, " Journal of Neuro-Oncology, vol. 107, no. 1, pp. 21-27, 2012.
4. C. Muller, J. Holtschmidt, M. Auer et al. , "Hematogenous dissemination of glioblastoma multiforme, " Science Translational Medicine, vol. 6, no. 247, p. 247ra101, 2014.
5. E. di Tomaso, M. Snuderl, W. S. Kamoun et al. , "Glioblastoma recurrence after cediranib therapy in patients: lack of 'rebound" revascularization as mode of escape, " Cancer Research, vol. 71, no. 1, pp. 19-28, 2011.
6. J. F. deGroot, G. Fuller, A. J. Kumar et al. , "Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice, " Neuro-Oncology, vol. 12, no. 3, pp. 233-242, 2010.
7. M. R. Mancuso, R. Davis, S. M. Norberg et al. , "Rapid vascular regrowth in tumors after reversal of VEGF inhibition, " Journal of Clinical Investigation, vol. 116, no. 10, pp. 2610-2621, 2006.
8. F. M. Iwamoto, L. E. Abrey, K. Beal et al. , "Patternsof relapse and prognosis after bevacizumab failure in recurrent glioblastoma, " Neurology, vol. 73, no. 15, pp. 1200-1206, 2009.
9. L. Ricci-Vitiani, R. Pallini, M. Biffoni et al. , "Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells, " Nature, vol. 468, no. 7325, pp. 824-830, 2010.
10. E. M. Thompson, E. P. Frenkel, and E. A. Neuwelt, "The paradoxical effect of bevacizumab in the therapy of malignant gliomas, " Neurology, vol. 76, no. 1, pp. 87-93, 2011.
11. D. Shweiki, A. Itin, D. Soffer, and E. Keshet, "Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis, " Nature, vol. 359, no. 6398, pp. 843-845, 1992.
12. B. Millauer, L. K. Shawver, K. H. Plate, W. Risau, andA. Ullrich, "Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant, " Nature, vol. 367, no. 6463, pp. 576-579, 1994.
13. T. T. Batchelor, P. Mulholland, B. Neyns et al. , "Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma, " Journal of Clinical Oncology, vol. 31, no. 26, pp. 3212-3218, 2013.
14. S. L. Gerson, "MGMT: its role in cancer aetiology and cancer therapeutics, " Nature Reviews Cancer, vol. 4, no. 4, pp. 296-307, 2004.
15. M. E. Hegi, A. -C. Diserens, T. Gorlia et al. , "MGMT gene silencing and benefit from temozolomide in glioblastoma, " The New England Journal ofMedicine, vol. 352, no. 10, pp. 997-1003, 2005.
16. G. Li, Z. Zhang, J. Zhang et al. , "Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review, " Diagnostic Pathology, vol. 9, no. 1, article 17, 2014.
17. M. Esteller, S. R. Hamilton, P. C. Burger, S. B. Baylin, and J. G. Herman, "Inactivation of the DNA repair gene O6-methylguanine-DNAmethyltransferase by promoter hypermethylation is a common event in primary human neoplasia, " Cancer Research, vol. 59, pp. 793-797, 1999.
18. V. Voelter, A. -C. Diserens, A. Moulin et al. , "Infrequent promoter methylation of theMGMT gene in liver metastases from uveal melanoma, " International Journal of Cancer, vol. 123, no. 5, pp. 1215-1218, 2008.
19. J. Brabender, H. Usadel, R. Metzger et al. , "Quantitative O6-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associationswith clinical outcome, " Clinical Cancer Research, vol. 9, no. 1, pp. 223-227, 2003.
20. M. R. J. Kohonen-Corish, W. A. Cooper, J. Saab, J. F. Thompson, R. J. A. Trent, andM. J. Millward, "Promoter hypermethylation of the O6-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma, " Journal of Investigative Dermatology, vol. 126, no. 1, pp. 167-171, 2006.
21. N. Shinojima, K. Tada, S. Shiraishi et al. , "Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme, " Cancer Research, vol. 63, no. 20, pp. 6962-6970, 2003.
22. U. Tabori, S. Rienstein, Y. Dromi et al. , "Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas, " Journal of Neurosurgery, vol. 103, no. 4, pp. 357-361, 2005.